Bain Capital Public Equity Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bain Capital Public Equity Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-207,889	Closed	-$8.14M	–	56
2014 Q1	$8.14M	Sell	207,889 -313,911	-60%	-$10.5M	0.22%	47
2013 Q4	$12.5M	Hold	521,800	–	–	0.35%	40
2013 Q3	$14.6M	Buy	+521,800	New	+$14.4M	0.37%	42

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TRV

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Bain Capital Public Equity Management's AGIO Position: Q2 2014 in Review

Bain Capital Public Equity Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2014, closing a stake of 207,889 shares — an estimated $8.14M sold.

Bain Capital Public Equity Management first reported a position in AGIO in Q3 2013 and held it in 3 quarters. The position peaked at $14.6M in Q3 2013. 99 funds tracked by Wall St. Rank hold AGIO as of Q2 2014.

Bain Capital Public Equity Management reported no remaining Agios Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Bain Capital Public Equity Management sold 207,889 Agios Pharmaceuticals shares in Q2 2014, an estimated $8.14M.
Bain Capital Public Equity Management first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 3 quarters.
Bain Capital Public Equity Management's Agios Pharmaceuticals position peaked at $14.6M in Q3 2013.
99 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2014.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2014, filed 13 Aug 2014.